ID: ALA5220234

Max Phase: Preclinical

Molecular Formula: C18H18N4O2

Molecular Weight: 322.37

Associated Items:

Representations

Canonical SMILES:  OCC/N=C/c1ccc2ccc3ccc(/C=N/CCO)nc3c2n1

Standard InChI:  InChI=1S/C18H18N4O2/c23-9-7-19-11-15-5-3-13-1-2-14-4-6-16(12-20-8-10-24)22-18(14)17(13)21-15/h1-6,11-12,23-24H,7-10H2/b19-11+,20-12+

Standard InChI Key:  SPZWSKWEVBZFID-AYKLPDECSA-N

Associated Targets(Human)

quadruplex DNA 2700 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.37Molecular Weight (Monoisotopic): 322.1430AlogP: 1.61#Rotatable Bonds: 6
Polar Surface Area: 90.96Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 3.06CX LogP: 2.16CX LogD: 2.16
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.53Np Likeness Score: -0.29

References

1. Figueiredo J, Carreira-Barral I, Quesada R, Mergny JL, Cruz C..  (2022)  Synthesis and evaluation of 2,9-disubstituted-1,10-phenanthroline derivatives as G-quadruplex binders.,  73  [PMID:36208542] [10.1016/j.bmc.2022.116971]

Source